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Bartonella bacilliformis is the causative agent of Carrion’s disease, a highly endemic human bartonellosis in Peru. We performed
a whole-genome assembly of two B. bacilliformis strains isolated from the blood of infected patients in the acute phase of Carri-
on’s disease from the Cusco and Piura regions in Peru.
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Carrion’s disease is a vector-borne neglected illness restricted toAndean valleys in Peru, Ecuador, and Colombia (1), where it
remains endemic. The causal agent of Carrion’s disease is Barto-
nella bacilliformis, an intracellular, nonfermentative, pleomor-
phic, Gram-negative microorganism, with Lutzomyia verrucarum
being the main illness vector.
This illness has two different phases. In the acute phase,
called Oroya fever, the intense destruction of erythrocytes leads
to a severe hemolytic anemia and temporal immunosuppres-
sion, which facilitates both the reactivation of silent illnesses,
such as tuberculosis or histoplasmosis, and the growth of op-
portunistic infections that may be fatal, such as bloodstream
Salmonella infections (1, 2). In fact, in the preantibiotic era,
Oroya fever was considered one of the most lethal infections,
having a mortality rate of up to 85% (3); at present, a 10%
mortality rate is reported in reference hospitals, even with cor-
rect antibiotic treatments (1).
The chronic phase is considered to take place months after
Oroya fever, due to the development of partial immunity, but it
may also be present even without a previous acute diagnosis.
This phase is characterized by the proliferation of verrucous
lesions, so-called verruga peruana. In this phase, the most se-
rious complication is the presence of verrucous lesion bleed-
ing, which in extreme cases may require blood transfusions (4).
Often, a clinical cure does not result in microbiological
clearance, leading to asymptomatic carriers, with persistent
B. bacilliformis bacteremia serving as a source for human-to-
human transmissions (1). Nonetheless, their real number re-
mains uncertain due to the lack of enough sensitive diagnosis
tools (5); additional genomic data may help close these gaps.
Sequencing of the two B. bacilliformis strains, USM-LMMB-
006 and USM-LMMB-007, collected in 2011 in southern (La
Convención, Cusco) and northern Peru (Huancabamba,
Piura), respectively, and identified as causal agents of Oroya
fever (6), was carried out at the genomics platform of the Ger-
mans Trias i Pujol Research Institute using an Illumina MiSeq
sequencer with a paired-end 300-bp sequencing kit. Using
Trimmomatic (7), low-quality reads were filtered out and
adapter sequences were trimmed. Quality-controlled sequence
reads were assembled using A5-miseq (8) small genome assem-
bly software (8). Protein-coding genes were predicted using the
NCBI Prokaryote Genome Annotation Pipeline (PGAP) (9).
The functions of the predicted protein-coding genes were an-
notated with the Clusters of Orthologous Groups (COG) (10)
database using the WebMGA (11) interface with standard pa-
rameters. For strains USM-LMMB-006 and USM-LMMB-007,
assemblies produced 15 and 11 scaffolds with median depths of
coverage of 72 and 77, total sizes of 1,401,011 and
1,405,613 bp, and GC contents of 38.0% and 38.0%, respec-
tively. The draft genomes of B. bacilliformis strains USM-
LMMB-006 and USM-LMMB-007 contained 1,136/1,135 cod-
ing sequences, 3/3 rRNAs, and 39/39tRNAs, respectively.
Using COG functional assignment, the 996 (88%) and 998
(88%) predicted proteins of strains USM-LMMB-006 and
USM-LMMB-007, respectively, could be classified into 868
COG families and 21 COG classes. The most abundant COG
classes in both strains were related to translation, ribosomal
structure, and biogenesis, including 135 predicted proteins in
both strains. The abundant classes in USM-LMMB-006 and
USM-LMMB-007 were general function (92/92); replication,
recombination, and repair (76/74); amino acid transport and
metabolism (76/76); and energy production and conversion
(72/72); 88/86 had unknown function.
Nucleotide sequence accessionnumbers.This whole-genome
shotgun project has been deposited at NCBI GenBank under the
sequence accession numbers LQWW00000000 (LQWW01000001 to
LQWW01000015) and LQXX00000000 (LQXX01000001 to
LQXX01000011) for strains USM-LMMB-006 and USM-LMMB-
007, respectively.
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